MAJA LETICA: Open Payments
NPI 1336788231 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 16 payments from 10 companies in 2025. Trend: 2023 $294 · 2024 $183 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $90 |
| PFIZER INC. | 3 | $55 |
| ABBVIE INC. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $35 |
| Biogen, Inc. | 1 | $28 |
| ARGENX US, INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| TG Therapeutics, Inc. | 1 | $18 |
Products named: UPLIZNA, NURTEC ODT, AUSTEDO XR, VUMERITY, BOTOX, VYVGART HYTRULO, AMYVID, WAINUA.
Industry payments across IA — which companies pay providers there.
